Schedule 13D ownership disclosure

INDIVIOR PLC

Ordinary Shares, $0.50 nominal value per share · CUSIP: G4766E116

Event date: 2025-11-10

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Oaktree Value Opportunities Fund, L.P.

    Shares: 5,005,808 · Class: 4%

  • Oaktree London Liquid Value Opportunities Fund (VOF), L.P.

    Shares: 2,108,224 · Class: 1.7%

  • Oaktree Phoenix Investment Fund, L.P.

    Shares: 310,503 · Class: 0.2%

  • Oaktree Capital Management, L.P.

    Shares: 1,320,549 · Class: 1.1%

  • Oaktree Fund GP I, L.P.

    Shares: 7,424,535 · Class: 5.9%

  • Oaktree Capital Holdings, LLCReported CIK 0001790787

    Shares: 8,745,084 · Class: 7%

  • Oaktree Capital Group Holdings GP, LLC

    Shares: 8,745,084 · Class: 7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001140361-25-042045
Form type
SCHEDULE 13D/A
Filer
Indivior Pharmaceuticals, Inc.
CIK
CIK 1625297
Filed
Nov 13, 2025
Reporting period
Nov 10, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub